With cholera on the rise around the world, the global vaccine stockpile is running dry. New doses go right to active outbreaks, with none left for prevention campaigns. Can vaccine makers catch up?
A panel of doctors and scientists advising the Centers for Disease Control and Prevention voted to recommend that people 6 months of age and older get new COVID boosters this fall.
Maybe it's not a full-blown summer surge but COVID numbers are ticking up. For those with concerns due to personal risk factors or the start of the school year, the booster question is top of mind.
The country's toll makes up nearly a third of the world's 619,000 malaria deaths each year. Now Nigeria has approved a new vaccine. Will it get into the arms of those who need it most?
The official emergency is over but COVID is still here. And that means ... lots of questions. We asked our readers what's on their mind and then called on experts for advice.
A cluster of mpox cases in the Chicago area has sparked fears of a summer wave. Health officials are pointing to new research showing the vaccine is effective and hoping people take notice.
The Food and Drug Administration appears poised to make available the COVID-19 vaccines that target omicron as a second booster for people with weak immune systems and those ages 65 and older.
Treating cholera has been a passion for Bangladeshi scientist Firdausi Qadri. She reflects on her career and inspirations, cholera's scourge, as well as successes in combating the disease.
Several crises in the country — including political instability, COVID and financial collapse — have created deteriorating conditions that have allowed the bacteria to spread.
Monkeypox is the latest case of how global health inequities persist. Vaccines went to the rich world while Africa lacks access. African scientists call for a bold plan to protect against pathogens.
A new report from the Lancet Commission sums up the many mistakes that have been made and offers proposals for a more effective global strategy if and when another pandemic should strike.
The Biden administration is supplying Georgia with up to 5,500 additional doses of monkeypox vaccine during Black Pride events in Atlanta this weekend.
Missteps and delays have hampered the U.S. effort to vaccinate people against monkeypox. Now state health officials and community members are trying to adapt to a controversial "dose sparing" plan.
The highly infectious viral disease can lead to permanent paralysis of the arms and legs and even death in some cases. Health officials are urging people to get vaccinated if they haven't been.
